Beyond Air. has been granted a patent for a device designed to deliver therapeutic gases, such as nitric oxide, to spontaneously breathing patients. The system ensures that gas delivery exceeds the patient’s inspiratory flow rate while minimizing gas waste, featuring a specialized reservoir tube and gas-tight patient interface. GlobalData’s report on Beyond Air gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Beyond Air Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on Beyond Air, Ambulatory infusion device was a key innovation area identified from patents. Beyond Air's grant share as of July 2024 was 29%. Grant share is based on the ratio of number of grants to total number of patents.

Therapeutic gas delivery system for spontaneously breathing patients

Source: United States Patent and Trademark Office (USPTO). Credit: Beyond Air Inc

The patent US12029847B2 describes a therapeutic gas delivery device specifically designed to administer nitric oxide to patients. The device features a reservoir tube with a larger volume than the patient's tidal volume, allowing for efficient gas flow. It includes a therapeutic gas inlet connected to a gas source, a patient interface that ensures a gas-tight seal, and a sampling port for monitoring gas characteristics. Additional components such as an exhalation check valve, an exhaust port, and a flow meter enhance the device's functionality by minimizing patient effort during inhalation and exhalation, as well as enabling real-time monitoring of gas parameters like concentration and flow rate.

Moreover, the device is equipped with alert mechanisms to notify users if monitored values deviate from preset thresholds, and it can adjust the flow rate or concentration of the therapeutic gas as needed. The patent specifies that the nitric oxide can be delivered at concentrations ranging from 0.5 ppm to 400 ppm, with a preferred concentration of 160 ppm in a mixture of oxygen and nitrogen. The design also includes features to ensure proper gas venting during exhalation, further optimizing the delivery of therapeutic gases to patients.

To know more about GlobalData’s detailed insights on Beyond Air, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.